Quantcast

Latest Cord blood bank Stories

2014-06-05 08:28:12

EYSINS, Switzerland, June 5, 2014 /PRNewswire/ -- In line with its mission of market innovator, Biosafe is proud to announce the launch of the SepaMax multiprocessing device, on the occasion of the International Cord Blood Symposium in San Francisco. (Logo: http://photos.prnewswire.com/prnh/20140407/679480 ) SepaMax is designed for high throughput cell processing. Based on Biosafe's industry-leading Sepax technology, it offers six processing modules in a...

2014-06-03 12:38:22

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Biobanking for Medicine: Technology, Industry and Market 2014-2024http://www.reportbuyer.com/pharma_healthcare/biotechnology/biobanking_medicine_technology_market.html Report DetailsBiobanks - how to find business trends, R&D, and revenue forecastsWhat does the future hold for medical biobanks? Now you get technological and commercial predictions from 2014. Stay ahead, then, for data,...

2014-06-03 12:37:18

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Translational Regenerative Medicine: Market Prospects 2014-2024http://www.reportbuyer.com/pharma_healthcare/research_r_d/translational_regenerative_medicine_market_prospects_2012_2022.html Report DetailsOur new study shows you the commercial potential of regenerative treatmentsWhat does the future hold for regenerative medicine? Visiongain's brand new report shows you potential revenues to...

2014-06-02 08:31:56

SACRAMENTO, Calif., June 2, 2014 /PRNewswire/ -- SynGen Inc., a company focused on the development and commercialization of instrument systems that harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood, and cell culture, announced today that Dr. William Gerber has been appointed CEO to replace co-founder and lead inventor Philip Coelho. Mr. Coelho, who will become the Chief Technical Officer (CTO) of SynGen, noted "Bud Barry, my business partner and...

2014-05-27 12:33:02

Americord Yields 60% More CD34+ Stem Cells, 54% More Cord Blood, and 34% Higher TNC Than Competitors NEW YORK, May 27, 2014 /PRNewswire/ -- Americord announced today that its cord blood stem cell collection statistics beat the cord blood banking industry averages by significant margins across three critical measures. An in-depth analysis of collection samples through March 31, 2014 revealed that Americord collects 60% more CD34+ stem cells, 54% higher volume, and 34% higher total...

2014-05-16 12:27:11

Abstract Presented at ASPHO Conference by Americord's Medical Director Dr. Robert Dracker NEW YORK, May 16, 2014 /PRNewswire/ -- Breakthrough technology that harvests stem cells from the placenta was presented in an abstract written by Dr. Robert A. Dracker, Americord's Executive Medical Director, at the 27(th) annual meeting of the American Society of Pediatric Hematology/Oncology (ASPHO). The new stem cell harvesting technology enables parents to collect as many as twice the...

2014-04-28 12:27:26

Americord CEO Interviewed For Article Exploring Good And Bad Practices In The Industry NEW YORK, April 28, 2014 /PRNewswire/ -- Americord Registry client Whitney Ferrarese was featured in an extensive front page Wall Street Journal article published last week about her family's positive experience with cord blood banking. Ms. Ferrarese and her husband chose Americord to store their first baby's cord blood after a long online search, and they plan to store their second baby's cord...

2014-04-22 23:13:31

(OTCQB:CCEL) Cryo-Cell International, Inc., the world’s first cord blood bank, announced today that parents are able to obtain better cord blood units for their babies through a new advanced processing technology. Cryo-Cell becomes the first nationwide private cord blood bank to license the new PrepaCyte CB technology from Pall Corporation (NYSE:PLL). Oldsmar, FL (PRWEB) April 22, 2014 New PrepaCyte® CB cord blood processing technology improves viable stem cell recovery and...

2014-04-15 08:30:55

SAN BRUNO, Calif., April 15, 2014 /PRNewswire/ -- Cord Blood Registry® (CBR®) announces the launch of an FDA-regulated clinical trial being conducted at The University of Texas Health Science Center at Houston to investigate two forms of stem cell therapy in children diagnosed with cerebral palsy. The randomized, placebo-controlled study aims to compare the safety and efficacy of an intravenous infusion of cord blood stem cells to bone marrow stem cells....

2014-04-11 12:23:51

DUBLIN, Apr. 11, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/qsm3wn/cord_blood ) has announced the addition of the "Cord Blood Banking Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Stem cells are capable of producing all the three types of blood cells produced in human body i.e. red blood cells, platelets and white...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related